SCHEMBL7818201

SCHEMBL7818201

O=C1c2ccccc2-c2c1c(Cl)nc1ccc(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
C1R P00736 1/20 0.46
S100A4 P26447 1/20 0.45
FABP4 P15090 4/20 0.44
FABP3 P05413 3/20 0.44
FABP5 Q01469 3/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK1 P28482 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818507 0.88 ELANE (0.46) MEN1KMT2AC1RS100A4TUBB4A
SCHEMBL6516391 0.85 PDE4B (0.43) MEN1KMT2AHTTSMN1; SMN2TUBB4A
SCHEMBL12781496 0.84 PABPC1 (0.47) MEN1KMT2AC1RLMNAHTT
SCHEMBL7820175 0.82 TP53 (0.51) KDM4EMEN1KMT2AC1RLMNA
SCHEMBL24122668 0.81 ADORA2A (0.50) KDM4EMEN1KMT2AFABP4FABP3
SCHEMBL7821797 0.81 KMT2A (0.51) MEN1KMT2AS100A4IDO1TDO2
SCHEMBL7820606 0.78 MEN1 (0.49) KDM4EMEN1KMT2ALMNASMN1; SMN2
SCHEMBL16895274 0.78 APAF1 (0.48) KDM4EMEN1KMT2AC1RS100A4
SCHEMBL3732268 0.78 PABPC1 (0.47) MEN1KMT2AC1RLMNAHTT
SCHEMBL7818757 0.77 TOP1 (0.56) KDM4EMEN1KMT2AHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0713870-B1 NOVEL FUSED INDAN DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2001-07-18 EP disclosed
US-6028079-A FOR TREATING TUMOR OF MAMMAL TAIHO PHARMACEUTICAL CO., LTD (JP) 2000-02-22 US disclosed
US-5733918-A ANTITUMOR AGENT TAIHO PHARMACEUTICAL CO., LTD. (JP) 1998-03-31 US disclosed
US-5710162-A ANTITUMOR AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 1998-01-20 US disclosed
EP-0713870-A1 NOVEL FUSED INDAN DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-05-29 EP disclosed